PT  - JOURNAL ARTICLE
AU  - Alsallom, Faisal A.
AU  - Sinha, Shobhit
AU  - Alsenani, Fahmi M.
AU  - Bamogaddam, Fawziah A.
AU  - Wahass, Saeed H.
AU  - Canillo, Aurora B.
AU  - Siddiqui, Khurram A.
TI  - Tolerability of propofol in Wada testing
DP  - 2014 Jul 01
TA  - Neurosciences Journal
PG  - 218--223
VI  - 19
IP  - 3
4099  - http://nsj.org.sa/content/19/3/218.short
4100  - http://nsj.org.sa/content/19/3/218.full
SO  - Neurosciences (Riyadh)2014 Jul 01; 19
AB  - Objective: To assess the tolerability of propofol (PF) in Wada test in an Arab population with temporal lobe epilepsy (TLE).Methods: This observational study with consecutive sampling took place in King Fahad Medical City, Riyadh, Saudi Arabia. Nine consecutive patients with mean (+SD) age of 26 (+5.8) years, 6 males and 3 females, underwent Wada test between January 2009 and December 2012. Six of them had left TLE, and 3 had right TLE. Each patient received 10 mg of PF in the internal carotid artery (ICA). Right hemispheric injection was followed by left hemisphere injection after 30 minutes. During the procedure, EEG monitoring showed changes within 5-18 seconds of injection as hemispheric delta slowing. Neuropsychological tests were carried out for localization of memory and language.Results: We were able to lateralize speech dominance in 8 patients and memory dominance in 6 patients. Peri-procedural complications included transient euphoria (n=1), transient spasm of ICA (n=1), eye pain (n=1), facial pain (n=1), and generalized tremulousness (n=2). None of the patients exhibited a symptomatic drop in blood pressure.Conclusions: We found that PF is well tolerable for the Wada test, with minimally significant complications, although blood pressure should be closely monitored.